Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Gargano, Nicola ^a   Ubben, David ^b   Tommasini, Silva ^a   Bacchieri, Antonella ^a   Corsi, Marco ^a   Bhattacharyya, Prabhash C ^d   Rao, Bappanad Hk ^e   Dubashi, Nagesh ^f   Dev, Vas ^c   Ghosh, Susanta K ^g   Kumar, Ashwani ^h   Srivastava, Bina ^c   Valecha, Neena ^c  

^a Sigma Tau SpA   (Italy)

^b Medicines for Malaria Venture MMV   (Switzerland)

^c NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^d Down Town Hospital   (India)

^e District Government Wenlock Hospital   (India)

^f GOA MEDICAL COLLEGE   (India)

^g National Institute of Malaria Research   (India)

^h National Institute of Malaria Research   (India)

Author keywords

Artemisinin based combination therapy (ACT); Artesunate; Dihydroartemisinin piperaquine; India; Malaria; Mefloquine; Plasmodium falciparum

Indexed keywords

ARTESUNATE PLUS MEFLOQUINE; DIAZEPAM; DIHYDROARTEMISININ PLUS PIPERAQUINE; FERRIC AMMONIUM CITRATE; LACTAB; MEFLOQUINE; MEPHA; PHENYTOIN; PRIMAQUINE; QUININE; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; ASTHENIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; FEMALE; FEVER; FOLLOW UP; GRAND MAL SEIZURE; HEMATOCRIT; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MULTICENTER STUDY; OPEN STUDY; PARASITE CLEARANCE; PARASITE INCIDENCE; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; ARTEMISININS; ASIA; DRUG THERAPY, COMBINATION; DRUG TOXICITY; FEMALE; HUMANS; INDIA; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; QUINOLINES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865218549     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-233     Document Type: Article

References (21)

1. An overview of malaria burden in India and road-blocks in its control. Jain S, Chugh TD, J Clin Diagnostic Res 2011 5 915 916
2. Burden of malaria in India: retrospective and prospective view. Kumar A, Valecha N, Jain T, Dash AP, AmJ Trop Med Hyg 2007 77 69 78
3. Knowledge, awareness and practices towards malaria in communities of rural, semi-rural and bordering areas of east Delhi India. Tyagi P, Roy A, Malhotra MS, J Vect Borne Dis 2005 42 30 35 (Pubitemid 40897326)
4. Battling the malaria iceberg with chloroquine in India. Sharma VP, Malar J 2007 6 105 10.1186/1475-2875-6-105 17683630 (Pubitemid 47507061)
5. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Shah NK, Dhillon GPS, Dash AP, Arora U, Meshnick SR, Valecha N, Lancet Infect Dis 2011 11 57 64 10.1016/S1473-3099(10)70214-0 21183147
6. Prescription practices and availability of artemisinin monotherapy in India: where do we stand? Mishra N, Anvikar AR, Shah NK, Kamal VK, Sharma SK, Srivastava HC, Das MK, Pradhan K, Kumar H, Gupta YK, Gupta P, Dash AP, Valecha N, Malar J 2011 10 360 10.1186/1475-2875-10-360 22166073
7. Dihydroartemisinin-piperaquine against multidrug-resistant P. falciparum malaria in Vietnam: randomized clinical trial. Tran TH, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, Dong TH, Tran TT, Stepniewska K, White NJ, Farrar J, Lancet 2004 363 18 22 10.1016/S0140-6736(03)15163-X 14723988 (Pubitemid 38076920)
8. Antimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertainties. Gargano N, Cenci F, Bassat Q, Trop Med Int Health 2011 16 1466 1473 10.1111/j.1365-3156.2011.02855.x
9. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia. Valecha N, Phyo AP, Mayxay M, Newton PN, Krudsood S, Keomany S, Khanthavong M, Pongvongsa T, Ruangveerayuth R, Uthaisil C, Ubben D, Duparc S, Bacchieri A, Corsi M, Rao BHK, Bhattacharya PC, Dubhashi N, Ghosh SK, Vas D, Kumar A, Pukrittayakamee S, PLoS One 2010 5 11880 10.1371/journal.pone.0011880
10. Chloroquine versus sulphadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet province, Lao Peoples Democratic Republic: an assessment of national antimalarial drug recommendations. Mayxay M, Newton PN, Khanthavong M, Tiengkham P, Phetsouvanh R, Phompida S, Brockman A, White NJ, Clin Infect Dis 2003 37 1021 1028 10.1086/377734 14523765 (Pubitemid 37323655)
11. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Brockman A, Paul RE, Anderson TJ, Hackford I, Phaiphun L, Looareesuwan S, Nosten F, Day KP, AmJTrop Med Hyg 1999 60 14 21 (Pubitemid 29065997)
12. Mating patterns in malaria parasite populations of Papua New Guinea. Paul RE, Packer MJ, Walmsley M, Lagog M, Ranford-Cartwright LC, Paru R, Day KP, Science 1995 269 1709 1711 10.1126/science.7569897 7569897 (Pubitemid 26449518)
13. World Health Organization, Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria World Health Organization, Geneva, Switzerland 2003 http://www.who.int/malaria/publications/ atoz/whohtmrbm200350/en/
14. The Analysis of Case-control Studies. Breslow NE, Day NE, Statistical Methods in Cancer Research. Volume 1 International Agency for Research on Cancer (IARC Scientific Publications n. 32), Lyon, France, Davis W, 1980
15. Malaria in India: the Center for the study of complex malaria in India. Das A, Anvikar AR, Cator LJ, Dhiman RC, Eapen A, Mishra N, Nagpal BN, Nanda N, Raghavendra K, Read AF, Sharma SK, Singh OP, Singh V, Sinnis P, Srivastava HC, Sullivan SA, Sutton PL, Thomas MB, Carlton JM, Valecha N, Acta Trop 2011 121 267 273 22142788
16. Million Death Study Collaborators: Adult and child malaria mortality in India: a nationally representative mortality survey. Dhingra N, Jha P, Sharma VP, Cohen AA, Jotkar RM, Rodriguez PS, Bassani DG, Suraweera W, Laxminarayan R, Peto R, Lancet 2010 376 1768 1774 10.1016/S0140-6736(10)60831-8 20970179
17. Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria. Rijken MJ, McGready R, Phyo AP, Lindegardh N, Tarning J, Laochan N, Than HH, Mu O, Win AK, Singhasivanon P, White N, Nosten F, Antimicrob Agents Chemother 2011 55 5500 5506 10.1128/AAC.05067-11 21947392
18. Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria. Ashley EA, Stepniewska K, Lindegårdh N, McGready R, Hutagalung R, Hae R, Singhasivanon P, White NJ, Nosten F, Antimicrob Agents Chemother 2006 50 2281 2285 10.1128/AAC.00040-06 16801402 (Pubitemid 43993164)
19. Multiple origins of Plasmodium falciparum dihydropteroate synthetase mutant alleles associated with sulfadoxine resistance in India. Lumb V, Das MK, Singh N, Dev V, Khan W, Sharma YD, Antimicrob Agents Chemother 2011 55 2813 2817 10.1128/AAC.01151-10 21422213
20. World Health Organization, World malaria report 2011 World Health Organization, Geneva, Switzerland 2011
21. Use of mefloquine in children-a review of dosage, pharmacokinetics and tolerability data. Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Bansod S, Rhein HG, Malar J 2011 10 292 10.1186/1475-2875-10-292 21981927